We report the development of mRNA overwriting therapy based on the engineered destabilization of the poly U stabilizing elements on the 3′UTR of MYC, which triggered nonsense-mediated decay to degrade the MYC transcript and protein, leading to the inhibition of c-MYC-driven TNBC and other cancers. Here, MYC is linked to cancer.